Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.57 |
| ▸ | NPC1 | O15118 | 3/20 | 0.57 |
| ▸ | RAB9A | P51151 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | GLA | P06280 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | KDM1A | O60341 | 1/20 | 0.50 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.49 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.49 |
| ▸ | APP | P05067 | 2/20 | 0.46 |
| ▸ | IKBKB | O14920 | 2/20 | 0.45 |
| ▸ | CCR1 | P32246 | 3/20 | 0.45 |
| ▸ | CCR5 | P51681 | 3/20 | 0.45 |
| ▸ | CCR8 | P51685 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27657937 | 1.00 | CYP19A1 (0.59) | CYP19A1KDM4ENPC1RAB9AMAPT | |
| SCHEMBL6230863 | 1.00 | CYP19A1 (0.59) | CYP19A1KDM4ENPC1RAB9AMAPT | |
| SCHEMBL30109437 | 1.00 | CYP19A1 (0.59) | CYP19A1KDM4ENPC1RAB9AMAPT | |
| SCHEMBL403651 | 0.98 | CYP19A1 (0.60) | CYP19A1KDM4ENPC1RAB9AMAPT | |
| SCHEMBL29415478 | 0.98 | CYP19A1 (0.60) | CYP19A1KDM4ENPC1RAB9AMAPT | |
| SCHEMBL30103498 | 0.96 | CYP19A1 (0.59) | CYP19A1KDM4ENPC1RAB9AMAPT | |
| SCHEMBL29675208 | 0.96 | CYP19A1 (0.59) | CYP19A1KDM4ENPC1RAB9AMAPT | |
| SCHEMBL31103353 | 0.92 | CYP19A1 (0.55) | CYP19A1KDM4ENPC1RAB9AMAPT | |
| Pyridine SCHEMBL29277407 | 0.92 | CYP19A1 (0.55) | CYP19A1KDM4ENPC1RAB9AMAPT | |
| SCHEMBL6419090 | 0.86 | IKBKB (0.47) | CYP19A1KDM4ENPC1RAB9AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1944308-B1 | PROCESS FOR PRODUCTION OF ORTHO-METALLIZED 1:3 COMPLEX OF IRIDIUM WITH HOMOLIGAND | NIPPON STEEL & SUMIKIN CHEM CO (JP) | 2013-10-02 | — | — | EP | disclosed |
| US-8034934-B2 | reacting iridium acetylacetonate with an organic ligands such as 2-phenylpyridine in the presence of acids, to form tris(2-phenylpyridine) iridium complex, used as a luminous material for an organic electroluminescent device, in high yield at high purity | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2011-10-11 | — | — | US | disclosed |
| EP-1191612-B1 | Luminescence device and display apparatus | CANON KK (JP) | 2009-09-09 | — | — | EP | disclosed |
| US-20080255361-A1 | Process for Producing Ortho-Metalated Complex of Iridium With Homoligand | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2008-10-16 | — | — | US | disclosed |
| EP-1944308-A1 | PROCESS FOR PRODUCTION OF ORTHO-METALLIZED 1:3 COMPLEX OF IRIDIUM WITH HOMOLIGAND | Nippon Steel Chemical Co., Ltd. (JP) | 2008-07-16 | — | — | EP | disclosed |
| US-7220495-B2 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2007-05-22 | — | — | US | disclosed |
| US-20050025996-A1 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2005-02-03 | — | — | US | disclosed |
| US-6821646-B2 | CAPABLE OF PROVIDING A HIGH-EFFICIENCY LUMINESCENT STATE AT A HIGH BRIGHTNESS (OR LUMINANCE) FOR A LONG PERIOD WHILE MINIMIZING THE DETERIORATION IN LUMINESCENCE IN ENERGIZED STATE | CANON KABUSHIKI KAISHA (JP) | 2004-11-23 | — | — | US | disclosed |
| US-20020063516-A1 | Limuninescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2002-05-30 | — | — | US | disclosed |
| EP-1191612-A2 | Luminescence device, display apparatus and metal coordination compound | CANON KABUSHIKI KAISHA (JP) | 2002-03-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080255361-A1 | Process for Producing Ortho-Metalated Complex of Iridium With Homoligand | HPD, TALDO1, PGD | CYP19A1 4223/4885KDM4E 3836/4885NPC1 4207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.